Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR S-1Filed 20 h ago

bioAffinity Technologies, Inc. files S-1 registration statement

Open the sourceReported by SEC EDGAR S-1, sec.gov, 20 November 2026, by SEC EDGAR S-1

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

bioAffinity Technologies, Inc. filed an S-1 registration statement with the SEC under accession number 0001493152-26-053519. The filing registers securities for potential sale, though the company did not disclose the offering size or pricing terms in the initial submission. The move signals the diagnostics developer's intent to raise capital or enable share resales through the public markets. Investors will watch for a preliminary prospectus supplement detailing the number of shares, use of proceeds and any selling stockholders.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR S-1's report. It can get details wrong, so check the source.

Named in this story

bioAffinity Technologies, Inc.